Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Onxeo SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Onxeo SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Onxeo SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Onxeo Enters into Research Agreement with Royal College of Surgeons in Ireland 11
Onxeo Enters into Agreement with Centro de Investigacion Medica Aplicada 12
Onxeo Enters into Agreement with Croix-Rousse Hospital and Centre de Recherche en Cancerologie 13
Onxeo Enters into Agreement with Synovo 14
DARA BioSciences Enters into Commercialization Agreement with Onxeo 15
Licensing Agreements 16
SWK Holdings Receives Beleodaq Royalty Rights from Onxeo 16
Monopar Therapeutics Enters into Licensing Agreement with Onxeo 17
Pint Pharma Enters into Licensing Agreement with Onxeo for Beleodaq 18
Onxeo Enters into Licensing Agreement with Bruno Farmaceutici 19
Equity Offering 20
Onxeo to Raise USD6.3 Million in Equity Financing 20
Onxeo Raises USD16.7 Million in Private Placement of Shares 22
Onxeo Raises USD14 Million in Private Placement of Shares 23
Onxeo to Raise USD1 Million in Private Placement of Shares 24
Onxeo Raises USD51 Million in Rights Offering 25
Asset Transactions 27
Vectans Pharma to Acquire Sitavig and Loramyc from Onxeo 27
Acquisition 28
Onxeo Acquires DNA Therapeutics 28
Onxeo SA – Key Competitors 29
Onxeo SA – Key Employees 30
Onxeo SA – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Joint Venture 31
Recent Developments 33
Financial Announcements 33
Jul 27, 2018: Onxeo Reports Half-Year 2018 Financial Results and Provides Business Outlook 33
May 16, 2018: Onxeo Provides Business Update and Reports First Quarter 2018 Financial Information 36
Mar 29, 2018: Onxeo Reports Full-Year 2017 Financial Results and Provides Business Update 37
Oct 26, 2017: Onxeo Provides Strategy Update and Reports 2017 Third Quarter Financial Information 40
Jul 28, 2017: Onxeo Reports First-Half 2017 Results and Business Update 41
Apr 26, 2017: Onxeo: Q1 2017 financial information and business update 43
Mar 07, 2017: Onxeo: Full-year 2016 Results and Outlook for 2017 44
Corporate Communications 46
Mar 01, 2017: Onxeo Appoints Seasoned Executives to Accelerate Preclinical and Clinical Development 46
Mar 01, 2017: Onxeo announces two new executive appointments 47
Legal and Regulatory 48
Jan 23, 2018: Onxeo Announces Update On Litigation with SpeBio/SpePharm 48
Product News 49
Oct 02, 2017: Onxeo Introduces platON, a Proprietary Chemistry Platform of Decoy Oligonucleotides 49
04/24/2017: Clinigen and Onxeo initiate Managed Access programme for belinostat in Europe for patients with peripheral T-cell lymphoma 50
03/31/2017: Spectrum Pharmaceuticals Highlights Two Abstracts on BELEODAQ (belinostat) for injection at the American Association for Cancer Research (AACR) Annual Meeting in Washington 51
03/21/2017: Onxeo to Present Data on Key Orphan Oncology Asset Beleodaq at AACR Annual Meeting 52
Other Significant Developments 53
Mar 14, 2018: Onxeo Provides Financial Update 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54
Onxeo SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Onxeo SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Onxeo SA, Deals By Therapy Area, 2012 to YTD 2018 9
Onxeo SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Onxeo Enters into Research Agreement with Royal College of Surgeons in Ireland 11
Onxeo Enters into Agreement with Centro de Investigacion Medica Aplicada 12
Onxeo Enters into Agreement with Croix-Rousse Hospital and Centre de Recherche en Cancerologie 13
Onxeo Enters into Agreement with Synovo 14
DARA BioSciences Enters into Commercialization Agreement with Onxeo 15
SWK Holdings Receives Beleodaq Royalty Rights from Onxeo 16
Monopar Therapeutics Enters into Licensing Agreement with Onxeo 17
Pint Pharma Enters into Licensing Agreement with Onxeo for Beleodaq 18
Onxeo Enters into Licensing Agreement with Bruno Farmaceutici 19
Onxeo to Raise USD6.3 Million in Equity Financing 20
Onxeo Raises USD16.7 Million in Private Placement of Shares 22
Onxeo Raises USD14 Million in Private Placement of Shares 23
Onxeo to Raise USD1 Million in Private Placement of Shares 24
Onxeo Raises USD51 Million in Rights Offering 25
Vectans Pharma to Acquire Sitavig and Loramyc from Onxeo 27
Onxeo Acquires DNA Therapeutics 28
Onxeo SA, Key Competitors 29
Onxeo SA, Key Employees 30
Onxeo SA, Subsidiaries 31
Onxeo SA, Joint Venture 31
List of Figures
Onxeo SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Onxeo SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Onxeo SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9